Drugs and Decision-making in the European Union
Author | : Tim Boekhout van Solinge |
Publisher | : |
Total Pages | : 0 |
Release | : 2002 |
Genre | : Drug abuse |
ISBN | : |
Download Drugs and Decision-making in the European Union Book in PDF, ePub and Kindle
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Drugs And Decision Making In The European Union PDF full book. Access full book title Drugs And Decision Making In The European Union.
Author | : Tim Boekhout van Solinge |
Publisher | : |
Total Pages | : 0 |
Release | : 2002 |
Genre | : Drug abuse |
ISBN | : |
Author | : M. Elvins |
Publisher | : Springer |
Total Pages | : 242 |
Release | : 2003-08-06 |
Genre | : Political Science |
ISBN | : 0230006167 |
Martin Elvins' book is the first to trace the evolution of anti-drugs policies at European Union level from the late 1960s to the present. Phases of drug policy development, key policy actors and institutions are described with particular reference to the influence of transnational networks of expertise. Policy development is placed in the context of both European integration and a broad harmonization of international policies against drug trafficking. Concerns are also raised about secretive and anti-democratic features on intergovernmental EU decision-making.
Author | : Tim Boekhout van Solinge |
Publisher | : |
Total Pages | : 182 |
Release | : 2002 |
Genre | : History |
ISBN | : |
Drugs are a perennial topic within the institutions of the European Union--the Commission, Council and Parlia-ment. The "drug problem" is also regularly tabled on the agenda of the European Council, the biannual summit of the government leaders of the fifteen member states. The E.U. systematically brings drug-related issues into virtually all of its political dialogues with Third World countries and regional organizations. It even stresses the importance of anti-drug measures as part of trade agreements and development cooperation. By such means, the European Union has become an important player in the world of international drug control. This book gives an overview of the European Union's anti-drug measures and focuses on its decision-making process. It looks at why drugs have acquired a prominent position on the European political agenda and identifies the political function they serve in terms of domestic drug policy and international relations. This study shows that instead of solving the drug problem, the European Union's bureaucracy actually helps to keep it alive and well. Tim Boekhout van Solinge is a researcher at the Centre for Drug Research of the University of Amsterdam.
Author | : European Monitoring Centre for Drugs and Drug Addiction |
Publisher | : Luxembourg : Office for Official Publications of the European Communities |
Total Pages | : 22 |
Release | : 2003 |
Genre | : Drug abuse |
ISBN | : |
Author | : Scott L. Greer |
Publisher | : World Health Organization |
Total Pages | : 191 |
Release | : 2017-11-20 |
Genre | : Law |
ISBN | : 9289050438 |
Civil Society Organizations (CSOs) can make a vital contribution to public health and health systems but harnessing their potential is complex in a Europe where government-CSO relations vary so profoundly. This study is intended to outline some of the challenges and assist policy-makers in furthering their understanding of the part CSOs can play in tandem and alongside government. To this end it analyses existing evidence and draws on a set of seven thematic chapters and six mini case studies. They examine experiences from Austria Bosnia-Herzegovina Belgium Cyprus Finland Germany Malta the Netherlands Poland the Russian Federation Slovenia Turkey and the European Union and make use of a single assessment framework to understand the diverse contexts in which CSOs operate. The evidence shows that CSOs are ubiquitous varied and beneficial and the topics covered in this study reflect such diversity of aims and means: anti-tobacco advocacy food banks refugee health HIV/AIDS prevention and cure and social partnership. CSOs make a substantial contribution to public health and health systems with regards to policy development service delivery and governance. This includes evidence provision advocacy mobilization consensus building provision of medical services and of services related to the social determinants of health standard setting self-regulation and fostering social partnership. However in order to engage successfully with CSOs governments do need to make use of adequate tools and create contexts conducive to collaboration. To guide policy-makers working with CSOs through such complications and help avoid some potential pitfalls the book outlines a practical framework for such collaboration. This suggests identifying key CSOs in a given area; clarifying why there should be engagement with civil society; being realistic as to what CSOs can or will achieve; and an understanding of how CSOs can be helped to deliver.
Author | : C. Chatwin |
Publisher | : Springer |
Total Pages | : 182 |
Release | : 2011-04-28 |
Genre | : Political Science |
ISBN | : 0230306837 |
Exploring the illegal drug issue in international context, this book looks at why harmonization has not already taken place at the European level. It considers the desirability and viability of harmonization, examines the conflict between repressive and liberal drug policies and applies a multi-level governance lens to the issue.
Author | : Pascal Fontaine |
Publisher | : |
Total Pages | : 114 |
Release | : 2017 |
Genre | : Europe |
ISBN | : 9789279535901 |
Author | : |
Publisher | : |
Total Pages | : 284 |
Release | : 2011 |
Genre | : Drug abuse |
ISBN | : 9789291684878 |
Author | : Sayaka Fukumi |
Publisher | : Routledge |
Total Pages | : 292 |
Release | : 2016-05-23 |
Genre | : Political Science |
ISBN | : 131716489X |
The post-Cold War world has seen the emergence of new kinds of security threats. Whilst traditionally security threats were perceived of in terms of military threats against a state, non-traditional security threats are those that pose a threat to various internal competencies of the state and its identity both home and abroad. The European Union and the United States have identified Latin American cocaine trafficking as a security threat, but their policy responses to it have differed. This book examines the ways in which the EU and the US have conceptualized this threat. Furthermore, it explores the impact of cocaine trafficking on four state functions - economic, political, public order and diplomatic - in order to explain why it has become 'securitized'. Appealing to a variety of university courses, this book is especially relevant to security studies and European and US policy analysis, as well as criminology and sociology.
Author | : National Academies of Sciences, Engineering, and Medicine |
Publisher | : National Academies Press |
Total Pages | : 169 |
Release | : 2020-04-25 |
Genre | : Medical |
ISBN | : 0309498635 |
Globalization is rapidly changing lives and industries around the world. Drug development, authorization, and regulatory supervision have become international endeavors, with most medicines becoming global commodities. Drug companies utilize global supply chains that often include facilities in countries with inconsistent regulations from those of the United States, perform pivotal trials in multiple countries to support registration submissions in various jurisdictions, and subsequently market their medicines throughout most of the world. These companies operate across borders and require individual national regulators to ensure that drugs authorized for use in their countries are safe and effective, and appropriate for their health care system and their population. This process involves significant resources and often duplicative work. It is important to consider how this process can be improved in order to better allocate resources, time, and efforts to improve public health. Regulating Medicines in a Globalized World: The Need for Increased Reliance Among Regulators considers the role of mutual recognition and other reliance activities among regulators in contributing to enhancing public health. This report identifies opportunities for leveraging reliance activities more broadly in order to potentially impact public health globally. Key topics in this report include the job of medicines regulators in today's world, what policy makers need to know about today's regulatory environment, stakeholder views of recognition and reliance, as well as removing impediments and facilitating action for greater recognition and reliance among regulatory authorities.